company

GLOBAL PHARMA GROUP AS

8470 BØ I VESTERÅLEN

Return on Equity
−14,38 %
Current Ratio
0,54
Debt-to-Equity Ratio
0,18
Key figures (NOK)2022
Revenue1 738 000
Net Income−1 592 000
Total Assets18 190 000
Total Equity11 072 000
Income (NOK)2022
Revenue1 738 000
Expenditure3 587 000
Operating Profit−1 849 000
Financial Income0
Financial Costs146 000
Financial Balance−146 000
Earnings Before Tax−1 994 000
Tax−402 000
Net Income−1 592 000
Balance (NOK)2022
Total Fixed Assets15 407 000
Total Current Assets2 783 000
Total Assets18 190 000
Total Retained Equity0
Total Equity11 072 000
Total Long-Term Debt2 000 000
Total Current Debt5 118 000
Total Equity and Debt18 190 000
Cash flow (NOK)2022
Sales Income93 000
Other Income1 645 000
Revenue1 738 000
Cost of Goods Sold75 000
Salary Costs2 277 000
Depreciation68 000
Impairment0
Expenditure3 587 000
Operating Profit−1 849 000
Financial Income0
Financial Costs146 000
Financial Balance−146 000
Dividends0
Net Income−1 592 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets455 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures452 000
Total Tangible Assets452 000
Total Fiancial Fixed Assets14 500 000
Total Fixed Assets15 407 000
Stock0
Total Investments0
Cash, Bank810 000
Total Current Assets2 783 000
Total Assets18 190 000
Total Equity11 072 000
Short-Term Group Debt0
Total Long-Term Debt2 000 000
Creditors103 000
Unpaid Taxes148 000
Dividends0
Other Current Debt4 867 000
Total Current Debt5 118 000
Total Equity and Debt18 190 000
Financial indicators2022
Return on Equity−14,38 %
Debt-to-Equity Ratio0,18
Operating Profit Margin−106,39 %
Current Ratio0,54
Quick Ratio0,54
Equity Ratio0,61
Gross Profit Margin95,68 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English